Results 141 to 150 of about 30,543 (245)

Management of antidepressant-induced bruxism [PDF]

Mental Health Clinician
Hayley Cliatt, PharmD, Andrew M. Williams, PharmD, BCPP, Jessa Koch, PharmD, BCPP   +2 more
doaj   +1 more source

Individual Cognitive Remediation Therapy and Individual Emotion Skills Training for Anorexia Nervosa: A Case Series Study in a Paediatric Ward

European Eating Disorders Review, Volume 34, Issue 4, Page 952-959, July 2026.
ABSTRACT Introduction Adolescents with anorexia nervosa (AN) often present cognitive rigidity, impaired decision‐making, and difficulties processing emotions, all of which can impede engagement in treatment. The marked rise in paediatric hospitalisations for AN during the COVID‐19 pandemic highlights the urgent need for brief, targeted interventions in
Dario Marin, Federica Tedde, Federico Muzzarelli, Paola Elisa Cogo, Lucia Giombini   +4 more
wiley   +1 more source

Patterns of psychotropic medication use, medication switching, augmentation, and non-persistence in adolescents and young adults with co-occurring psychiatric morbidities and opioid use disorder. [PDF]

BMC Psychiatry
Liu L, McKnight ER, Bonny AE, Lemelin K, Cai Y, Nahata MC.   +5 more
europepmc   +1 more source

Association of treatment for prenatal depression with cardiovascular disease within 24 months after delivery

Pregnancy, Volume 2, Issue 4, July 2026.
Abstract Introduction While the strong association of prenatal depression with an increased risk of new cardiovascular disease (CVD) within 24 months postpartum has been demonstrated in two distinct cohorts, it is unclear if treatment of prenatal depression may mitigate this risk.
Christina M. Ackerman‐Banks, Kristin Palmsten, Heather S. Lipkind, Katherine A. Ahrens   +3 more
wiley   +1 more source

Case Report: Fluoxetine-induced leucocytoclastic vasculitis. [PDF]

Front Psychiatry
Qin Y, Yao J, Jiang X, Chen W.
europepmc   +1 more source

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder

British Journal of Pharmacology, Volume 183, Issue 14, Page 3970-3991, July 2026.
Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid‐acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood.
Laith Alexander, Dasha Anderson, Luke Baxter, Matthew Claydon, James Rucker, Emma S. J. Robinson   +5 more
wiley   +1 more source

The Infamous SSRIs

Journal of Science, Humanities and Arts - JOSHA, 2022
openaire   +1 more source

A Narrative Review of Augmentation Strategies in Obsessive-Compulsive Disorder: Antipsychotics as Mainstay and Emerging Role of Extended-Release Methylphenidate. [PDF]

Pharmaceuticals (Basel)
Grigaitytė J, Strumila R.
europepmc   +1 more source

Neuropsychopharmacology of hallucinogenic and non‐hallucinogenic 5‐HT2A receptor agonists

British Journal of Pharmacology, Volume 183, Issue 14, Page 3935-3949, July 2026.
Psychedelic drugs such as LSD and psilocin were once relegated to the fringes of medical research because of their association with counterculture movements and a perceived concern about harm through recreational use, and their consequent legal prohibition in the early 1970s.
Trevor Sharp, Aurelija Ippolito
wiley   +1 more source

Placental and fetal consequences of maternal selective serotonin reuptake inhibitor use: current evidence and unresolved questions. [PDF]

Front Pharmacol
Crossen MJ, Hernandez LL.
europepmc   +1 more source